LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...

Quantum technology first in eye disease detection

Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).

Tech supplier search to help tackle 8am rush at GP surgeries

Tech specialists are being sought to help tackle the 8am rush for appointments at GP surgeries.

Researchers pursue personalised pathways for glaucoma care

Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.